#Colchicine in acutely decompensated #heartfailure: the COLICA trial released at #ESCCongress and just published in #EHJ👉 bit.ly/4gjU3JR EHJ Editor-in-Chief #HF Domingo Pascual-Figal Borja Ibanez

📌 Will you be at #ESCCongress in London this weekend? If so, don’t miss the presentation of Enrique Lara-Pezzi @cnic_cardio Basic and Translational Late-Breaking Science: "Distinct cellular and molecular trajectories leading to subclinical diastolic dysfunction and the progression to

And another paper online simultaneously with #ESCCongress! With Dr. Valentin Fuster and colleagues CNIC, we clarify the relationship between clonal hematopoiesis and atherosclerosis. Nature Medicine nature.com/articles/s4159… More details ➡️ bit.ly/3Z8hi38

An honor to share many moments with you at #ACVC_ESC European Society of Cardiology and Soc Esp Cardiología board. Great awarded Héctor Bueno. Big congratulations CNIC

José Javier Fuster CNIC Nature Medicine Congrats José Javier Fuster for your leadership! PESA-CNIC-Santander Study is not only informing clinical practice guidelines but also serving as an amazing tool for great basic science discoveries!! You are a 🎸 🌟 CNIC

👏 Esto es un gran resumen!!! 👏

📢 New European Society of Cardiology guidelines presented at #ESCCongress cite 11 key studies from CNIC on #syndromecoronarychronic #hypertension and #peripheral arterial and aortic diseases📄. A further endorsement for CNIC's translational approach 👏Betina Ybañez Ministerio de Ciencia, Innovación y Universidades

It has been my pleasure to serve as Task Force coordinator of the 2023 🫀 ESC Guidelines for the management of acute coronary syndromes 💔, and the 2024 ESC Guidelines for chronic coronary syndrome 🩺 Now, looking forward to new challenges, projects & collaborations 🔬 🌎 📝

Insightful and beautifully written editorial by Roger Blumenthal & Seth Martin on long-term importance of LDL-C, hsCRP, & Lp(a) in CVD prevention. Very helpful framing of critical role of early risk assessment and proactive prevention strategies in improving CV outcomes.

CardioTomLuscher Fantastic congress indeed!! Now it is time for MADRID!! 🙌❗️

Valentin Fuster Nuevo Factor de Riesgo Cardiovascular Ivan Mendoza SIAC Sociedad Venezolana de Cardiología CNIC isanidad.com/291825/el-cnic… ivanovich

In a meta-research analysis leveraging 120 mega-trials, meta-analyses of smaller studies showed overall comparable results with mega-trials, but smaller trials published before the mega-trials gave more favorable results than mega-trials. These findings suggest that mega-trials

Madri+d

El Hospital Universitario Ruber Juan Bravo se une al proyecto RESILIENCE, que tiene como objetivo reducir la insuficiencia cardíaca en pacientes con #cáncer i.mtr.cool/jexnzgidmk

🧠💓 Amazing opportunity for researchers! CNIC opens the second call for Cure Heart & Brain, a #COFUND program for excellent researchers of any nationality to perform research on heart and brain and their connection. Funded by the Marie Skłodowska-Curie Actions European Commission FICYT

🔬 Prevenir el daño cardiaco causado por fármacos contra el cáncer: objetivo del proyecto #RESILIENCE coordinado desde el CNIC por @borjaibanez1 y desde la European Society of Cardiology por la Dra. Teresa López-Fernández. El ensayo busca nuevas terapias para la #cardiotoxicidad inducida

Borja Ibanez European Society of Cardiology Soc Esp Cardiología CIBERCV Fundación Jiménez Díaz Cardiología FJD Noticia completa 📰👉cnic.es/es/noticias/pr…

Aclarando las guías de SCA con Borja Ibanez coordinador de las mismas European Society of Cardiology Journals Chechu Jiménez Mazuecos Enrique Gutierrez Macarena Javi Moreiras Un panel de lujo.

El CNIC investiga cómo reducir la prevalencia de insuficiencia cardiaca en personas que han sobrevivido al cáncer La Vanguardia RESILIENCE H2020 Borja Ibanez #InvestigaciónCáncer lavanguardia.com/sociedad/20240…